Henan Newland Pharmaceutical Co. Ltd. A (301277) — Net Asset Momentum
Henan Newland Pharmaceutical Co. Ltd. A (301277) recorded a net asset momentum of 0.5% as of December 2025, with net assets of CN¥1.55 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Henan Newland Pharmaceutical Co. Ltd. A shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Henan Newland Pharmaceutical Co. Ltd. A Net Asset Momentum (2020–2025)
This chart tracks Henan Newland Pharmaceutical Co. Ltd. A's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is +0.5%, with net assets of CN¥1.55 Billion CNY as of December 2025. For live market cap and overall valuation, see 301277 market cap overview.
Annual Net Asset History for Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)
The table below shows the complete annual net asset history for Henan Newland Pharmaceutical Co. Ltd. A from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Henan Newland Pharmaceutical Co. Ltd. A tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.55 Billion | CN¥1.78 Billion | CN¥228.49 Million | ▲ +0.5% |
| 2024 | CN¥1.54 Billion | CN¥1.81 Billion | CN¥270.69 Million | ▲ +6.5% |
| 2023 | CN¥1.45 Billion | CN¥1.61 Billion | CN¥160.02 Million | ▲ +6.6% |
| 2022 | CN¥1.36 Billion | CN¥1.53 Billion | CN¥174.58 Million | ▲ +234.5% |
| 2021 | CN¥406.38 Million | CN¥667.90 Million | CN¥261.53 Million | ▲ +29.7% |
| 2020 | CN¥313.39 Million | CN¥521.96 Million | CN¥208.57 Million | — |